We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Pharmacyclics Initiates Phase 1 Clinical Trial of Oral Btk Inhibitor for Refractory B-cell Non-Hodgkin's Lymphoma

News   Apr 15, 2009

 
Pharmacyclics Initiates Phase 1 Clinical Trial of Oral Btk Inhibitor for Refractory B-cell Non-Hodgkin's Lymphoma
 
 
 

RELATED ARTICLES

Defective Metabolic Pathway Corrected in Aged Mouse T Cells

News

T cell-mediated immune responses are compromised in aged individuals, leading to increased morbidity and reduced response to vaccination. Finding new ways to boost T cell immunity in the elderly is key for enhancing their immune competence.

READ MORE

A New Formulation Helps the Medicine Go Down

News

Scientists have developed a novel pharmaceutical formulation to administer triclabendazole - an anti-parasitic drug used to treat a type of flatworm infection - in billions of tiny capsules.

READ MORE

50% of Trial Subjects Who Took a Placebo Reported Suffering an Adverse Event

News

New research published in Trials explores the negative effects that can be caused by participants being administered placebos in clinical trials, finding that half of people taking placebos reported side effects from the trial intervention.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE